JP2021500882A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021500882A5 JP2021500882A5 JP2020521861A JP2020521861A JP2021500882A5 JP 2021500882 A5 JP2021500882 A5 JP 2021500882A5 JP 2020521861 A JP2020521861 A JP 2020521861A JP 2020521861 A JP2020521861 A JP 2020521861A JP 2021500882 A5 JP2021500882 A5 JP 2021500882A5
- Authority
- JP
- Japan
- Prior art keywords
- chimeric polypeptide
- region
- stalk
- polypeptide according
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023118889A JP2023153866A (ja) | 2017-10-18 | 2023-07-21 | スペーサーを含むポリペプチド組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762574061P | 2017-10-18 | 2017-10-18 | |
| US62/574,061 | 2017-10-18 | ||
| PCT/US2018/056334 WO2019079486A1 (en) | 2017-10-18 | 2018-10-17 | POLYPEPTIDE COMPOSITIONS COMPRISING SPACERS |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023118889A Division JP2023153866A (ja) | 2017-10-18 | 2023-07-21 | スペーサーを含むポリペプチド組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021500882A JP2021500882A (ja) | 2021-01-14 |
| JP2021500882A5 true JP2021500882A5 (https=) | 2021-11-25 |
Family
ID=66096807
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020521861A Pending JP2021500882A (ja) | 2017-10-18 | 2018-10-17 | スペーサーを含むポリペプチド組成物 |
| JP2023118889A Pending JP2023153866A (ja) | 2017-10-18 | 2023-07-21 | スペーサーを含むポリペプチド組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023118889A Pending JP2023153866A (ja) | 2017-10-18 | 2023-07-21 | スペーサーを含むポリペプチド組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11771718B2 (https=) |
| EP (1) | EP3697438A4 (https=) |
| JP (2) | JP2021500882A (https=) |
| KR (2) | KR20250010043A (https=) |
| CN (1) | CN111511391B (https=) |
| AU (2) | AU2018352984B2 (https=) |
| CA (1) | CA3079264A1 (https=) |
| IL (2) | IL316522A (https=) |
| SG (1) | SG11202003543WA (https=) |
| WO (1) | WO2019079486A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3105816A1 (en) * | 2018-07-10 | 2020-01-16 | Precigen, Inc. | Ror-1 specific chimeric antigen receptors and uses thereof |
| CN113039206A (zh) * | 2018-08-31 | 2021-06-25 | 西雅图儿童医院（Dba西雅图儿童研究所） | 包含b7h3嵌合抗原受体的方法和组合物 |
| AU2019377461A1 (en) * | 2018-11-06 | 2021-05-27 | Washington University | Chimeric antigen receptor memory-like (CARML) NK cells and methods of making and using same |
| WO2020214937A1 (en) * | 2019-04-19 | 2020-10-22 | Allogene Therapeutics, Inc. | Antibodies against 4g7-derived chimeric antigen receptors |
| TW202110873A (zh) | 2019-04-30 | 2021-03-16 | 美商聖堤生物科技股份有限公司 | 嵌合受體及其使用方法 |
| SE544015C2 (en) * | 2019-06-18 | 2021-11-02 | Tx Medic Ab | Allogenic car-t cell therapy |
| WO2020254591A1 (en) * | 2019-06-19 | 2020-12-24 | Julius-Maximilians-Universität Würzburg | Ultramodular igg3-based spacer domain and multi-function site for implementation in chimeric antigen receptor design |
| AU2020355031A1 (en) | 2019-09-24 | 2022-05-19 | The Regents Of The University Of California | Notch receptors with hinge domain |
| CN112111014A (zh) * | 2020-09-22 | 2020-12-22 | 廖文强 | 一种抗氧化嵌合型抗原受体和免疫细胞 |
| AU2022205683A1 (en) * | 2021-01-11 | 2023-07-06 | Precigen, Inc. | Chimeric receptor therapy |
| WO2022170093A2 (en) * | 2021-02-05 | 2022-08-11 | University Of Utah Research Foundation | Compositions and methods for treating with car cells |
| US12144827B2 (en) | 2021-02-25 | 2024-11-19 | Lyell Immunopharma, Inc. | ROR1 targeting chimeric antigen receptor |
| WO2022233956A1 (en) | 2021-05-05 | 2022-11-10 | Immatics Biotechnologies Gmbh | Antigen binding proteins specifically binding prame |
| WO2025038646A1 (en) * | 2023-08-14 | 2025-02-20 | Intellia Therapeutics, Inc. | Cd70 car-t compositions and methods for cell-based therapy |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3253628A1 (en) | 2010-03-05 | 2025-11-29 | The Johns Hopkins University | Compositions and methods for targeted immunomodulatory antibodies and fusion proteins |
| ES2602743T3 (es) * | 2010-09-08 | 2017-02-22 | Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus | Receptores de antígenos quiméricos con una región bisagra optimizada |
| ES2654060T3 (es) | 2011-10-20 | 2018-02-12 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Receptores de antígenos quiméricos anti-CD22 |
| WO2013112986A1 (en) * | 2012-01-27 | 2013-08-01 | Gliknik Inc. | Fusion proteins comprising igg2 hinge domains |
| BR122020002986A8 (pt) | 2012-08-20 | 2023-04-18 | Seattle Childrens Hospital Dba Seattle Childrens Res Inst | Método e composições para imunoterapia celular |
| EP3783098A1 (en) | 2013-05-14 | 2021-02-24 | Board Of Regents, The University Of Texas System | Human application of engineered chimeric antigen receptor (car) t-cells |
| EP3087101B1 (en) * | 2013-12-20 | 2024-06-05 | Novartis AG | Regulatable chimeric antigen receptor |
| NZ759969A (en) | 2013-12-20 | 2022-12-23 | Fred Hutchinson Cancer Center | Tagged chimeric effector molecules and receptors thereof |
| KR102375998B1 (ko) * | 2014-02-14 | 2022-03-21 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 키메라 항원 수용체 및 제조방법 |
| CA2939411A1 (en) * | 2014-02-27 | 2015-09-03 | Ucl Business Plc | Ligand |
| US10611837B2 (en) | 2014-04-10 | 2020-04-07 | Seattle Children's Hospital | Transgene genetic tags and methods of use |
| LT3194434T (lt) | 2014-09-15 | 2019-09-25 | Molmed Spa | Chimeriniai antigeno receptoriai |
| BR112017007003A2 (pt) | 2014-10-07 | 2017-12-19 | Cellectis | método para modulação de atividade de células imunes induzidas por car |
| WO2016168769A1 (en) | 2015-04-15 | 2016-10-20 | The California Institute For Biomedical Research | Chimeric receptor t cell switches for her2 |
| EP3307876B1 (en) | 2015-06-10 | 2023-09-13 | ImmunityBio, Inc. | Modified nk-92 cells for treating cancer |
| CN107709356A (zh) | 2015-06-26 | 2018-02-16 | 南加利福尼亚大学 | 用于肿瘤特异性活化的掩蔽嵌合抗原受体t细胞 |
| AU2016306209B2 (en) | 2015-08-07 | 2023-07-06 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Bispecific CAR T-cells for solid tumor targeting |
| AU2016361451B2 (en) * | 2015-11-27 | 2024-01-25 | Cartherics Pty. Ltd. | Genetically modified cells and uses thereof |
| CA3024725A1 (en) | 2016-06-06 | 2017-12-14 | Juno Therapeutics, Inc. | Methods for the treatment of b cell malignancies using adoptive cell therapy |
| CA3025667A1 (en) * | 2016-06-08 | 2017-12-14 | Intrexon Corporation | Cd33 specific chimeric antigen receptors |
| EP3568474A1 (en) * | 2017-01-10 | 2019-11-20 | Intrexon Corporation | Modulating expression of polypeptides via new gene switch expression systems |
| CA3065930A1 (en) * | 2017-06-07 | 2018-12-13 | Intrexon Corporation | Expression of novel cell tags |
| US11319380B2 (en) * | 2018-06-04 | 2022-05-03 | Precigen, Inc. | MUC16 specific chimeric antigen receptors and uses thereof |
| AU2019301070B2 (en) * | 2018-07-09 | 2025-09-11 | Precigen, Inc. | Fusion constructs and methods of using thereof |
| CA3105816A1 (en) * | 2018-07-10 | 2020-01-16 | Precigen, Inc. | Ror-1 specific chimeric antigen receptors and uses thereof |
| WO2022011256A1 (en) * | 2020-07-10 | 2022-01-13 | Precigen, Inc. | Fusion constructs and methods of using thereof |
| AU2022205683A1 (en) * | 2021-01-11 | 2023-07-06 | Precigen, Inc. | Chimeric receptor therapy |
-
2018
- 2018-10-17 US US16/163,233 patent/US11771718B2/en active Active
- 2018-10-17 IL IL316522A patent/IL316522A/en unknown
- 2018-10-17 IL IL273961A patent/IL273961B2/en unknown
- 2018-10-17 SG SG11202003543WA patent/SG11202003543WA/en unknown
- 2018-10-17 JP JP2020521861A patent/JP2021500882A/ja active Pending
- 2018-10-17 EP EP18869303.0A patent/EP3697438A4/en active Pending
- 2018-10-17 AU AU2018352984A patent/AU2018352984B2/en active Active
- 2018-10-17 WO PCT/US2018/056334 patent/WO2019079486A1/en not_active Ceased
- 2018-10-17 KR KR1020247040963A patent/KR20250010043A/ko active Pending
- 2018-10-17 KR KR1020207013590A patent/KR102742741B1/ko active Active
- 2018-10-17 CN CN201880082078.9A patent/CN111511391B/zh active Active
- 2018-10-17 CA CA3079264A patent/CA3079264A1/en active Pending
-
2023
- 2023-06-29 US US18/344,421 patent/US20230414661A1/en active Pending
- 2023-07-21 JP JP2023118889A patent/JP2023153866A/ja active Pending
- 2023-12-13 AU AU2023282226A patent/AU2023282226B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021500882A5 (https=) | ||
| EP3472205B1 (en) | Chimeric antigen receptor | |
| JP2023091037A (ja) | Ｇタンパク質共役受容体を標的化するキメラ抗原受容体およびその使用 | |
| JP2020511136A5 (https=) | ||
| JP2022109953A5 (https=) | ||
| JP2022113880A5 (https=) | ||
| JP7382829B2 (ja) | キメラ抗原受容体を発現するｔ細胞 | |
| JP2023085527A5 (https=) | ||
| JP2022105558A (ja) | 新規のポリペプチド | |
| RU2019133199A (ru) | Улучшенные форматы антигенсвязывающего рецептора | |
| JP7566628B2 (ja) | キメラ抗原受容体を発現する免疫細胞 | |
| JP2018508219A5 (https=) | ||
| JP2022523961A5 (https=) | ||
| JP2019150066A5 (https=) | ||
| JP2017507917A5 (https=) | ||
| JP2017527310A5 (https=) | ||
| JP2020511949A5 (https=) | ||
| JP2016534717A5 (https=) | ||
| RU2017133637A (ru) | Иммуномодулирующие слитые белки и пути их применения | |
| RU2018118652A (ru) | Химерные конструкции антитело/т-клеточный рецептор и их применения | |
| JP2020530989A5 (https=) | ||
| Murad et al. | Advances in the use of natural receptor-or ligand-based chimeric antigen receptors (CARs) in haematologic malignancies | |
| JP2018516092A5 (https=) | ||
| WO2017176525A1 (en) | Car having replicated binding motifs in a co-stimulatory domain | |
| RU2017102769A (ru) | EGFRvIII СПЕЦИФИЧЕСКИЕ ХИМЕРНЫЕ АНТИГЕННЫЕ РЕЦЕПТОРЫ ДЛЯ ИММУНОТЕРАПИИ РАКА |